A.P. Pharma Announces Executive Officer Departure
The company will be conducting a search for a new Chief Financial Officer. Until a successor is engaged Gregory Turnbull, the company's current President and Chief Executive Officer, will also handle the duties of the Chief Financial Officer on an interim basis.
About A.P. Pharma
A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer(TM). Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com.
A.P. Pharma, Inc.
President and Chief Executive Officer
Investor Relations Contacts:
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
Posted: January 2008